Why the study?
Heart failure recurrence is higher in patients with diabetes, and given the close association and shared risk factors between the two diseases, it was unknown whether therapies for type 2 diabetes could affect heart failure management.
Do therapies for type 2 diabetes reduce the progression of heart failure symptoms in patients with heart failure and diabetes?
Do therapies for type 2 diabetes reduce the progression of heart failure symptoms in patients with heart failure and diabetes?
Therapies for type 2 diabetes may have a beneficial effect on reducing the progression of heart failure symptoms.
Many studies have revealed that the recurrence of heart failure (HF) in patients with diabetes is significantly higher than that in patients without diabetes, and insulin resistance and abnormal glucose metabolism are common in patients with HF. Therefore, heart failure is an important clinical problem in diabetic patients. Diabetes and heart failure are "killers" that go hand in hand. They share common risk factors. Patients with heart failure frequently have hyperglycemia, and heart failure is a typical complication for diabetic patients. Based on the possible association between the two diseases, this paper will further analyze the therapies of type 2 diabetes (T2DM) and explore whether it can have an effect on how to address heart failure. The study's findings demonstrated that treating type 2 diabetes did have some influence on the management of heart failure and that treating type 2 diabetes did reduce the progression of heart failure symptoms.
No takes yet. Share an insight, caveat, or question.
Qingyi Huang (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: